It is the scourge of many a middle-aged man: He starts getting a pot belly, using lighter weights at the gym and just doesn’t have the sexual desire of his younger years.
The obvious culprit is testosterone, because men gradually make less of the male sex hormone as years go by. But a surprising new answer is emerging, one doctors say could reinvigorate the study of how men’s bodies age. Estrogen, the primary female sex hormone, turns out to play a much bigger role in men’s bodies than previously thought, and falling levels contribute to their expanding waistlines just as they do in women’s.
The discovery of the role of estrogen in men is “a major advance,” said Dr. Peter Snyder, a professor of medicine at the University of Pennsylvania, who is leading a new research project on hormone therapy for men 65 and older. Until recently, testosterone deficiency was considered nearly the sole reason that men undergo the familiar physical complaints of midlife.
Some people call the midlife decline “male menopause” although men don’t menstruate and testosterone doesn’t fall off as sharply with age as estrogen does in women after menopause.
- Beloved Mama's Mexican Kitchen in Belltown to close
- Washington officer shoots men accused of earlier beer theft
- Paul Allen's First & Goal signs letter expressing concerns over Sodo arena
- Seattle no longer America's fastest-growing big city
- West Seattle couple leaves all their assets -- $847,215 -- to Uncle Sam
Most Read Stories
“Andropause would be more reasonable,” because testosterone is an androgen, a male sex hormone, said John Morley, an expert on hormone therapies and aging at Saint Louis University.
The new research involves figuring out which hormone does what in men, and how body functions are affected at different hormone levels. While dwindling testosterone levels are to blame for middle-aged men’s smaller muscles, falling levels of estrogen regulate fat accumulation, according to a study published Wednesday in The New England Journal of Medicine that provided the most conclusive evidence to date that estrogen is a major factor in men’s midlife woes. Both hormones are needed for libido.
“Some of the symptoms routinely attributed to testosterone deficiency are actually partially or almost exclusively caused by the decline in estrogens,” Joel Finkelstein, an endocrinologist at Harvard Medical School and the study’s lead author, said in a news release Wednesday.
His study is only the start of what many hope will be a new understanding of testosterone and estrogen in men.
Snyder is leading another study, the Testosterone Trial, which measures levels of both hormones and asks whether testosterone treatment can make older men with low testosterone levels more youthful — letting them walk more quickly, feel more vigorous, improve their sexual functioning and their memories, and strengthen their bones. Smaller studies have been promising but unreliable, and estrogen has not been factored in.
“We had ignored this hormone in men, but we are studying it now,” said Dr. Alvin Matsumoto, a testosterone and geriatrics researcher at the University of Washington School of Medicine and the V.A. Puget Sound Health Care System, who is a Testosterone Trial researcher. “We are just starting out on this road.”
Men and women make estrogen out of testosterone, and men make so much that they end up with at least twice as much estrogen as postmenopausal women. As levels of both hormones decline with age, the body changes. Until now, researchers have focused almost exclusively on how estrogen affects women and how testosterone affects men.
Finkelstein’s study provides a new road map of the function of each hormone and its behavior at various levels. It suggests that different symptoms kick in at different levels of testosterone deficiency. Testosterone, he found, is the chief regulator of muscle tone and lean body mass, but it takes less than was thought to maintain muscle. For a young man, 550 nanograms of testosterone per deciliter of blood serum is the average level, and doctors have generally considered levels below 300 nanograms so low they might require treatment, typically with testosterone gels.
But Finkelstein’s study found that muscle strength and size turn out to be unaffected until testosterone levels drop very low, below 200 nanograms. Fat accumulation, however, kicks in at higher testosterone levels: 300 to 350 nanograms of testosterone.
As for sexual desire and performance, both require estrogen and testosterone, and they increase steadily as those hormone levels rise. Researchers say it is too early to make many specific recommendations, but no one is suggesting men take estrogen because high doses cause feminine features, such as enlarged breasts.
Although doctors often prescribe testosterone gels for men whose levels fall below 300 nanograms per deciliter, that cutoff point is arbitrary, and there is no clinical rationale for it, Finkelstein said.
Today, millions of men are using testosterone gels, fueling a nearly $2 billion market.
For their study, Finkelstein and his colleagues recruited 400 men aged 20 to 50 who agreed to have their testosterone production turned off for 16 weeks. Half then received varying amounts of testosterone, while the other half also got a drug that shuts off estrogen synthesis so the researchers could assess the effects of having testosterone but not estrogen.
It turned out to be surprisingly easy to recruit subjects, Finkelstein said. One, Ben Iverson, joined in part for the $1,000 subjects were paid. “That, to me, was enticing,” he said. He was a 28-year-old Harvard graduate student at the time and is now an assistant professor of finance at Northwestern University.
Although his wife looked askance at the injections to block testosterone production, Iverson ended up getting enough testosterone in the gel he was assigned to use. The worst were the testosterone-suppressing injections, which required him to use a huge needle in his abdomen once a month, he said.